Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
11/13/2003 | US20030211056 Mixture of polyether and active whitening agent; adhesion to teeth |
11/13/2003 | US20030211055 Mixture of water soluble hydrogen peroxide generator and pH adjuster |
11/13/2003 | US20030211047 High speed absorption; mixture of aqueous polar solvent, propellant, active material and flavor |
11/13/2003 | US20030211046 Methods and formulations for the efficient delivery of water-insoluble drugs by nebulizer |
11/13/2003 | US20030211045 Magnetoliposome composition for targeted treatment of biological tissue and associated methods |
11/13/2003 | US20030211042 Measuring stomach discharging; analyzing emisison in breath; calibration |
11/13/2003 | US20030211035 Emulsion/aggregation polymeric microspheres for biomedical applications and methods of making same |
11/13/2003 | US20030209240 Method and apparatus for vaporizing a compound |
11/13/2003 | US20030209057 Controlling particle size of powder; mixing, heating metal particles in matrix |
11/13/2003 | CA2787384A1 Polymeric adhesive transdermal patch comprising rotigotine for treatment of restless leg syndrome |
11/13/2003 | CA2749172A1 Re-epithelializing pharmaceutical compositions comprising xanthan gum |
11/13/2003 | CA2491708A1 Non-viral gene delivery system |
11/13/2003 | CA2487274A1 Spermine chemically linked to lipids and cell-specific targeting molecules as a transfection agent |
11/13/2003 | CA2485116A1 Use of epa and dha in secondary prevention |
11/13/2003 | CA2485115A1 The treatment of pain with ifenprodil |
11/13/2003 | CA2485024A1 Centralized medical device configuration system |
11/13/2003 | CA2484965A1 Encapsulated cells to elicit immune response |
11/13/2003 | CA2484874A1 Monocompartment osmotic controlled drug delivery system |
11/13/2003 | CA2484621A1 Carvedilol formulations |
11/13/2003 | CA2484329A1 Warming and nonirritating anhydrous lubricant compositions |
11/13/2003 | CA2484318A1 Warming and nonirritating lubricant antifungal gel compositions |
11/13/2003 | CA2484212A1 Crystallization system utilizing atomization |
11/13/2003 | CA2484206A1 Computer assisted remotely controlled infusion therapy system |
11/13/2003 | CA2484151A1 Colored hard capsules |
11/13/2003 | CA2483929A1 A method for inhibiting platelet aggregation |
11/13/2003 | CA2483917A1 Formulations limiting spread of pulmonary infections |
11/13/2003 | CA2483656A1 Reduced formate poly(alkylene oxide) for a controlled release dosage form of reboxetine |
11/13/2003 | CA2483655A1 Methods and dosage forms for controlled delivery of oxycodone |
11/13/2003 | CA2483552A1 Calicheamicin derivative-carrier conjugates |
11/13/2003 | CA2483456A1 Delivery of microparticle-conjugated drugs for inhibition of stenosis |
11/13/2003 | CA2483120A1 Polymeric adhesive transdermal patch comprising rotigotine for treatment of restless leg syndrome |
11/13/2003 | CA2483099A1 Stable pharmaceutical formulation for a combination of a statin and an ace inhibitor |
11/13/2003 | CA2482780A1 Apparatus and method for delivery of constrained beneficial bacteria to the vaginal tract |
11/12/2003 | EP1361258A1 Capsules printed with sepia colored containing inks |
11/12/2003 | EP1361227A2 [5-carboxamide or 5-fluoro]-[2', 3'-unsaturated or 3'-modifield]-pyrimidine nucleosides |
11/12/2003 | EP1360988A1 Dehydrating agent and method for dehydrating moist article using the agent and dehydrated article obtained by the method |
11/12/2003 | EP1360958A2 Liposomic formulation of clobetasol propionate |
11/12/2003 | EP1360957A1 Vitamin/mineral complex |
11/12/2003 | EP1360956A1 Cleanser compositions |
11/12/2003 | EP1360904A1 Protected compound formulations of amino acids and process for their preparation |
11/12/2003 | EP1360189A1 Formulation of boronic acid compounds |
11/12/2003 | EP1360169A2 Succinate salt of o-desmethyl-venlafaxine |
11/12/2003 | EP1360168A2 Amphiphilic derivatives for the production of vesicles, micelles and complexants, and precursors thereof |
11/12/2003 | EP1360167A1 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use |
11/12/2003 | EP1359976A1 Fluid retention assembly for an iontophoretic delivery |
11/12/2003 | EP1359957A1 A drug delivery device |
11/12/2003 | EP1359947A2 A suspension comprising fibrinogen, thrombin and alcohol and a method of coating a carrier with the same |
11/12/2003 | EP1359946A1 Resorbable bone cement containing active agents |
11/12/2003 | EP1359942A1 Targetted anti-tumor drug delivery systems |
11/12/2003 | EP1359930A2 Novisprins: antimicrobial peptides |
11/12/2003 | EP1359927A1 Herbal pharmaceutical compositions for treating immunological disorders |
11/12/2003 | EP1359912A2 Novel methods using pyridine derivatives |
11/12/2003 | EP1359903A2 Method and device for producing thin wafers from a film of active ingredients |
11/12/2003 | EP1359902A2 Bimodal dry powder formulation for inhalation |
11/12/2003 | EP1359901A2 Thermolabile liposome with controlled release temperature |
11/12/2003 | EP1359900A1 A stable pharmaceutical formulation comprising torsemide modification ii |
11/12/2003 | EP1359899A1 Composition and method for controlled release injections |
11/12/2003 | EP1359898A1 Oral drug delivery system |
11/12/2003 | EP1359872A2 Vertebroplasty injection device and bone cement therefor |
11/12/2003 | EP1359864A1 Irradiated stent coating |
11/12/2003 | EP1359810A1 Water soluble powders and tablets |
11/12/2003 | EP1255557B1 Stable, nasally, orally or sublingually applicable pharmaceutical preparation containing desmopressin |
11/12/2003 | EP1233973B1 Partial or full a1 agonists - n6 heterocyclic 5'-thio substituted adenosine derivatives |
11/12/2003 | EP1229909B1 Transdermal delivery of lasofoxifene |
11/12/2003 | EP1216057B1 Stable calcitriol solution for packaging in vials |
11/12/2003 | EP1214062B1 Use of nicotinic acetylcholine receptor agonists for the preparation of a medicament for the treatment of dry eye disease |
11/12/2003 | EP1178819B1 Glutathione reductase for therapy and prophylaxis of aids |
11/12/2003 | EP1146895B1 Thrombopoietin compositions for increasing circulating platelets |
11/12/2003 | EP1140128B1 Method of using steam ironing of fabrics as a way of causing reduction of physiological and/or subjective reactivity to stress in humans |
11/12/2003 | EP1137400B1 Compositions containing a peptide and polylactic-glycolic acid suitable for preparing subcutaneous implants with an extended release period toff, verfahren zu seiner herstellung und anlage zur durchfuhrung des verfahrens |
11/12/2003 | EP1087750B1 Pharmaceutical formulations for aerosols with two or more active substances |
11/12/2003 | EP1069886B1 Use of a topical formulation of the oil-in-water type, comprising galactolipid material as emulsifier, for providing a prolonged effect of an incorporated active substance |
11/12/2003 | EP1032390B1 Anaesthetic formulation |
11/12/2003 | EP0986403B1 Composition with extended shelf-life storage comprising cyclodextrin and drugs or prodrugs that decompose to water-insoluble components |
11/12/2003 | EP0979087B1 Analgesic combination |
11/12/2003 | EP0969883B1 Implant for subcutaneous or intradermal injection |
11/12/2003 | EP0944383B1 Pharmaceutical suspension systems |
11/12/2003 | EP0938369B1 Emulsifier mixtures and their use for preparing pit emulsions |
11/12/2003 | EP0847272B1 LIPOSOMAL p-ETHOXY OLIGONUCLEOTIDES |
11/12/2003 | EP0804163B1 Improved method for stabilization of biological substances during drying and subsequent storage and compositions thereof |
11/12/2003 | EP0775203B1 Method of gene therapy using dna vectors without selection marker gene |
11/12/2003 | EP0752883B1 Use of mcp-1 for inducing ripening of the cervix |
11/12/2003 | EP0745382B1 Intraorally soluble compressed molding and process for producing the same |
11/12/2003 | CN1455818A Biodegradable articles obtained from enzymatically synthesized amylose |
11/12/2003 | CN1455772A Preventive or remedial agent for allergic disease and medical water-based liquid preparation, eye drop and nasal drop |
11/12/2003 | CN1455691A Pharmaceutical compositions |
11/12/2003 | CN1455681A Contraception process and administration for same |
11/12/2003 | CN1455678A Methods of therapy with thrombin derived peptides |
11/12/2003 | CN1455669A Esmolol formulation |
11/12/2003 | CN1455666A Externally-applicated chewing gum including chip-like center |
11/12/2003 | CN1455665A Medicinal composition |
11/12/2003 | CN1455664A Method of coating fine particle with lipid film |
11/12/2003 | CN1455663A Novel aerosol formulation containing polar fluorinated molecule |
11/12/2003 | CN1455660A Apparatus for puncturing needlike body into living tissue |
11/12/2003 | CN1455659A Treatment for high pressure bleeding |
11/12/2003 | CN1454901A Gynaecological anti-infective specificity IgY and its combined preparation |
11/12/2003 | CN1454667A Convenient fibrin blocking agent |
11/12/2003 | CN1454663A Compound artemisia rupestris capsule |
11/12/2003 | CN1454662A Wart-removing ointment |
11/12/2003 | CN1454651A Medicine for curing cardio-cerebrovascular disease |